11 February 2019 2 Min Read
Drug firm makes cholesterol pill more affordable
Sanofi and Regeneron cut list price by 60% to give US consumers better access and to lower out-of-pocket costs
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In